You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 4, 2026

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases
Published on: August 27, 2021
1Department of Immunology, Imperial College School of Medicine, London, UK.
Monoclonal antibody (mAb) technology has limitations. A new method using recombinant DNA and phage display enables the creation of novel antibody reagents for research and clinical use.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: